S&P 500   3,808.72 (-1.06%)
DOW   30,624.45 (-1.01%)
QQQ   324.99 (-1.10%)
AAPL   143.82 (+0.46%)
MSFT   238.72 (+2.75%)
FB   275.06 (-2.48%)
GOOGL   1,849.92 (-3.04%)
AMZN   3,305.96 (-0.61%)
TSLA   879.80 (-0.37%)
NVDA   524.77 (-2.35%)
BABA   262.65 (-1.23%)
CGC   36.06 (+1.52%)
GE   10.88 (-3.63%)
MU   76.60 (-3.66%)
AMD   90.03 (-4.94%)
NIO   59.20 (-1.84%)
T   29.78 (+0.10%)
F   10.90 (-2.59%)
ACB   10.75 (+0.75%)
BA   195.59 (-3.20%)
DIS   162.24 (-4.32%)
NFLX   544.22 (-3.15%)
GILD   65.45 (-1.87%)
S&P 500   3,808.72 (-1.06%)
DOW   30,624.45 (-1.01%)
QQQ   324.99 (-1.10%)
AAPL   143.82 (+0.46%)
MSFT   238.72 (+2.75%)
FB   275.06 (-2.48%)
GOOGL   1,849.92 (-3.04%)
AMZN   3,305.96 (-0.61%)
TSLA   879.80 (-0.37%)
NVDA   524.77 (-2.35%)
BABA   262.65 (-1.23%)
CGC   36.06 (+1.52%)
GE   10.88 (-3.63%)
MU   76.60 (-3.66%)
AMD   90.03 (-4.94%)
NIO   59.20 (-1.84%)
T   29.78 (+0.10%)
F   10.90 (-2.59%)
ACB   10.75 (+0.75%)
BA   195.59 (-3.20%)
DIS   162.24 (-4.32%)
NFLX   544.22 (-3.15%)
GILD   65.45 (-1.87%)
S&P 500   3,808.72 (-1.06%)
DOW   30,624.45 (-1.01%)
QQQ   324.99 (-1.10%)
AAPL   143.82 (+0.46%)
MSFT   238.72 (+2.75%)
FB   275.06 (-2.48%)
GOOGL   1,849.92 (-3.04%)
AMZN   3,305.96 (-0.61%)
TSLA   879.80 (-0.37%)
NVDA   524.77 (-2.35%)
BABA   262.65 (-1.23%)
CGC   36.06 (+1.52%)
GE   10.88 (-3.63%)
MU   76.60 (-3.66%)
AMD   90.03 (-4.94%)
NIO   59.20 (-1.84%)
T   29.78 (+0.10%)
F   10.90 (-2.59%)
ACB   10.75 (+0.75%)
BA   195.59 (-3.20%)
DIS   162.24 (-4.32%)
NFLX   544.22 (-3.15%)
GILD   65.45 (-1.87%)
S&P 500   3,808.72 (-1.06%)
DOW   30,624.45 (-1.01%)
QQQ   324.99 (-1.10%)
AAPL   143.82 (+0.46%)
MSFT   238.72 (+2.75%)
FB   275.06 (-2.48%)
GOOGL   1,849.92 (-3.04%)
AMZN   3,305.96 (-0.61%)
TSLA   879.80 (-0.37%)
NVDA   524.77 (-2.35%)
BABA   262.65 (-1.23%)
CGC   36.06 (+1.52%)
GE   10.88 (-3.63%)
MU   76.60 (-3.66%)
AMD   90.03 (-4.94%)
NIO   59.20 (-1.84%)
T   29.78 (+0.10%)
F   10.90 (-2.59%)
ACB   10.75 (+0.75%)
BA   195.59 (-3.20%)
DIS   162.24 (-4.32%)
NFLX   544.22 (-3.15%)
GILD   65.45 (-1.87%)
Log in
OTCMKTS:ALIOF

(ALIOF) Stock Forecast, Price & News

$278.50
0.00 (0.00 %)
(As of 01/26/2021 12:00 AM ET)
Add
Compare
Today's Range
$278.50
Now: $278.50
$278.50
50-Day Range
$278.50
MA: $278.50
$278.50
52-Week Range
$138.01
Now: $278.50
$286.30
VolumeN/A
Average Volume924 shs
Market Capitalization$29.89 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.21
Actelion Ltd. develops, produces and markets pharmaceutical drugs. The firm specializes in research, development, manufacturing, and distribution of pharmaceutical, biological, and diagnostic products. The company was founded by Jean-Paul Clozel, Martine Clozel, Walter Fischli, André J. Müller and Thomas Widmann on December 30, 1999 and is headquartered in Allschwil, Switzerland.
(ALIOF) logo

MarketRank

Overall MarketRank

0.42 out of 5 stars

Medical Sector

1658th out of 1,925 stocks

Medicinals & Botanicals Industry

24th out of 33 stocks

Analyst Opinion: 0.0Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Medicinals & botanicals
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:ALIOF
CUSIPN/A
CIKN/A
Phone(161) 565-6565
EmployeesN/A
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Market Cap$29.89 billion
Next Earnings DateN/A
OptionableNot Optionable
$278.50
0.00 (0.00 %)
(As of 01/26/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ALIOF News and Ratings via Email

Sign-up to receive the latest news and ratings for ALIOF and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











(ALIOF) (OTCMKTS:ALIOF) Frequently Asked Questions

How has (ALIOF)'s stock price been impacted by Coronavirus (COVID-19)?

(ALIOF)'s stock was trading at $278.50 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, ALIOF shares have increased by 0.0% and is now trading at $278.50.
View which stocks have been most impacted by COVID-19
.

What stocks does MarketBeat like better than (ALIOF)?

Wall Street analysts have given (ALIOF) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but (ALIOF) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How were (ALIOF)'s earnings last quarter?

(ALIOF) (OTCMKTS:ALIOF) issued its quarterly earnings data on Monday, February, 16th. The company reported $0.87 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.09 by $0.22. The company had revenue of $501.50 million for the quarter, compared to the consensus estimate of $546.30 million.
View (ALIOF)'s earnings history
.

Who are some of (ALIOF)'s key competitors?

Who are (ALIOF)'s key executives?

(ALIOF)'s management team includes the following people:
  • Nicholas Franco, Chief Business Development Officer & EVP
  • Christian Albrich, VP & Head-Global Human Resources

What is (ALIOF)'s stock symbol?

(ALIOF) trades on the OTCMKTS under the ticker symbol "ALIOF."

How do I buy shares of (ALIOF)?

Shares of ALIOF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is (ALIOF)'s stock price today?

One share of ALIOF stock can currently be purchased for approximately $278.50.

How big of a company is (ALIOF)?

(ALIOF) has a market capitalization of $29.89 billion.

What is (ALIOF)'s official website?

The official website for (ALIOF) is www.actelion.com.

How can I contact (ALIOF)?

(ALIOF)'s mailing address is Gewerbestrasse 16, Allschwil V8, 4123. The company can be reached via phone at (161) 565-6565 or via email at [email protected]

This page was last updated on 1/27/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.